These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33705117)

  • 1. Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design.
    Schoeder CT; Schmitz S; Adolf-Bryfogle J; Sevy AM; Finn JA; Sauer MF; Bozhanova NG; Mueller BK; Sangha AK; Bonet J; Sheehan JH; Kuenze G; Marlow B; Smith ST; Woods H; Bender BJ; Martina CE; Del Alamo D; Kodali P; Gulsevin A; Schief WR; Correia BE; Crowe JE; Meiler J; Moretti R
    Biochemistry; 2021 Mar; 60(11):825-846. PubMed ID: 33705117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RosettaCM for antibodies with very long HCDR3s and low template availability.
    Kodali P; Schoeder CT; Schmitz S; Crowe JE; Meiler J
    Proteins; 2021 Nov; 89(11):1458-1472. PubMed ID: 34176159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robustification of RosettaAntibody and Rosetta SnugDock.
    Jeliazkov JR; Frick R; Zhou J; Gray JJ
    PLoS One; 2021; 16(3):e0234282. PubMed ID: 33764990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants.
    Guest JD; Vreven T; Zhou J; Moal I; Jeliazkov JR; Gray JJ; Weng Z; Pierce BG
    Structure; 2021 Jun; 29(6):606-621.e5. PubMed ID: 33539768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Tools for Aiding Rational Antibody Design.
    Krawczyk K; Dunbar J; Deane CM
    Methods Mol Biol; 2017; 1529():399-416. PubMed ID: 27914064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based cross-docking analysis of antibody-antigen interactions.
    Kilambi KP; Gray JJ
    Sci Rep; 2017 Aug; 7(1):8145. PubMed ID: 28811664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practically useful: what the Rosetta protein modeling suite can do for you.
    Kaufmann KW; Lemmon GH; Deluca SL; Sheehan JH; Meiler J
    Biochemistry; 2010 Apr; 49(14):2987-98. PubMed ID: 20235548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling and docking of antibody structures with Rosetta.
    Weitzner BD; Jeliazkov JR; Lyskov S; Marze N; Kuroda D; Frick R; Adolf-Bryfogle J; Biswas N; Dunbrack RL; Gray JJ
    Nat Protoc; 2017 Feb; 12(2):401-416. PubMed ID: 28125104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design.
    Adolf-Bryfogle J; Kalyuzhniy O; Kubitz M; Weitzner BD; Hu X; Adachi Y; Schief WR; Dunbrack RL
    PLoS Comput Biol; 2018 Apr; 14(4):e1006112. PubMed ID: 29702641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in NMR Protein Structure Prediction with ROSETTA.
    Koehler Leman J; Künze G
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of antibody-antigen complex sequence-to-structure prediction methods and their systematic biases.
    McCoy KM; Ackerman ME; Grigoryan G
    Protein Sci; 2024 Sep; 33(9):e5127. PubMed ID: 39167052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Web-accessible molecular modeling with Rosetta: The Rosetta Online Server that Includes Everyone (ROSIE).
    Moretti R; Lyskov S; Das R; Meiler J; Gray JJ
    Protein Sci; 2018 Jan; 27(1):259-268. PubMed ID: 28960691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macromolecular modeling and design in Rosetta: recent methods and frameworks.
    Leman JK; Weitzner BD; Lewis SM; Adolf-Bryfogle J; Alam N; Alford RF; Aprahamian M; Baker D; Barlow KA; Barth P; Basanta B; Bender BJ; Blacklock K; Bonet J; Boyken SE; Bradley P; Bystroff C; Conway P; Cooper S; Correia BE; Coventry B; Das R; De Jong RM; DiMaio F; Dsilva L; Dunbrack R; Ford AS; Frenz B; Fu DY; Geniesse C; Goldschmidt L; Gowthaman R; Gray JJ; Gront D; Guffy S; Horowitz S; Huang PS; Huber T; Jacobs TM; Jeliazkov JR; Johnson DK; Kappel K; Karanicolas J; Khakzad H; Khar KR; Khare SD; Khatib F; Khramushin A; King IC; Kleffner R; Koepnick B; Kortemme T; Kuenze G; Kuhlman B; Kuroda D; Labonte JW; Lai JK; Lapidoth G; Leaver-Fay A; Lindert S; Linsky T; London N; Lubin JH; Lyskov S; Maguire J; Malmström L; Marcos E; Marcu O; Marze NA; Meiler J; Moretti R; Mulligan VK; Nerli S; Norn C; Ó'Conchúir S; Ollikainen N; Ovchinnikov S; Pacella MS; Pan X; Park H; Pavlovicz RE; Pethe M; Pierce BG; Pilla KB; Raveh B; Renfrew PD; Burman SSR; Rubenstein A; Sauer MF; Scheck A; Schief W; Schueler-Furman O; Sedan Y; Sevy AM; Sgourakis NG; Shi L; Siegel JB; Silva DA; Smith S; Song Y; Stein A; Szegedy M; Teets FD; Thyme SB; Wang RY; Watkins A; Zimmerman L; Bonneau R
    Nat Methods; 2020 Jul; 17(7):665-680. PubMed ID: 32483333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Peptide-Protein Structure and Binding Using Monte Carlo Sampling Approaches: Rosetta FlexPepDock and FlexPepBind.
    Alam N; Schueler-Furman O
    Methods Mol Biol; 2017; 1561():139-169. PubMed ID: 28236237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards the accurate modelling of antibody-antigen complexes from sequence using machine learning and information-driven docking.
    Giulini M; Schneider C; Cutting D; Desai N; Deane CM; Bonvin AMJJ
    Bioinformatics; 2024 Oct; 40(10):. PubMed ID: 39348157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody modeling assessment.
    Almagro JC; Beavers MP; Hernandez-Guzman F; Maier J; Shaulsky J; Butenhof K; Labute P; Thorsteinson N; Kelly K; Teplyakov A; Luo J; Sweet R; Gilliland GL
    Proteins; 2011 Nov; 79(11):3050-66. PubMed ID: 21935986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model Building of Antibody-Antigen Complex Structures Using GBSA Scores.
    Shimba N; Kamiya N; Nakamura H
    J Chem Inf Model; 2016 Oct; 56(10):2005-2012. PubMed ID: 27618247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocols for Molecular Modeling with Rosetta3 and RosettaScripts.
    Bender BJ; Cisneros A; Duran AM; Finn JA; Fu D; Lokits AD; Mueller BK; Sangha AK; Sauer MF; Sevy AM; Sliwoski G; Sheehan JH; DiMaio F; Meiler J; Moretti R
    Biochemistry; 2016 Aug; 55(34):4748-63. PubMed ID: 27490953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serverification of molecular modeling applications: the Rosetta Online Server that Includes Everyone (ROSIE).
    Lyskov S; Chou FC; Conchúir SÓ; Der BS; Drew K; Kuroda D; Xu J; Weitzner BD; Renfrew PD; Sripakdeevong P; Borgo B; Havranek JJ; Kuhlman B; Kortemme T; Bonneau R; Gray JJ; Das R
    PLoS One; 2013; 8(5):e63906. PubMed ID: 23717507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-molecule ligand docking into comparative models with Rosetta.
    Combs SA; Deluca SL; Deluca SH; Lemmon GH; Nannemann DP; Nguyen ED; Willis JR; Sheehan JH; Meiler J
    Nat Protoc; 2013; 8(7):1277-98. PubMed ID: 23744289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.